Phibro Animal Health | PAHC - Валовая прибыль





Валовая прибыль Изменить Дата
Align Technology USD 757.43M 20.84M 2026-06
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Aurora Cannabis CAD 29.79M 16.83M 2026-03
Bristol-Myers Squibb USD 8.07B 338M 2026-03
Canopy Growth CAD 8.26M 13.2M 2026-03
Corcept Therapeutics USD 252.09M 90.07M 2026-06
Eli Lilly USD 15.92B 1.33B 2025-12
Henry Schein USD 1.07B 7M 2026-03
Idexx Laboratories USD 722.74M 64.62M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Merck USD 10.85B 2.57B 2025-12
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Pacira USD 126.64M 15.61M 2026-03
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 157.37M 5.79M 2025-12
Supernus Pharmaceuticals USD 129.36M 34.68M 2026-03
Zoetis USD 1.62B 20M 2026-03